A Curve‐Free Method for Phase I Clinical Trials (Q4667490): Difference between revisions
From MaRDI portal
Created claim: Wikidata QID (P12): Q52076810, #quickstatements; #temporary_batch_1711574657256 |
ReferenceBot (talk | contribs) Changed an Item |
||
| Property / cites work | |||
| Property / cites work: Tailfree and neutral random probabilities and their posterior distributions / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: A Bayesian nonparametric approach to determining a maximum tolerated dose / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Continual Reassessment Method: A Likelihood Approach / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: On the distribution of the product of independent beta random variables / rank | |||
Normal rank | |||
Revision as of 09:12, 10 June 2024
scientific article; zbMATH DE number 2159529
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Curve‐Free Method for Phase I Clinical Trials |
scientific article; zbMATH DE number 2159529 |
Statements
A Curve‐Free Method for Phase I Clinical Trials (English)
0 references
20 April 2005
0 references
continual reassessment method
0 references
dose-finding studies
0 references
maximum tolerated dose
0 references
neutral to the right process
0 references
phase I clinical trial
0 references
product-of-beta priors
0 references
toxicity
0 references
0 references
